Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study (Q71041217)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1996

Language	Label	Description	Also known as
English	Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study	scientific article published on 01 July 1996

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lange BJ

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Blatt J

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Sather HN

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Meadows AT

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 July 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Pediatric Blood Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

15-20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Differences in prognosis for boys and girls with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Home care involving methotrexate infusions for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

The pharmacology and clinical use of methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Prognostic Significance of Methotrexate and 6-Mercaptopurine Dosage During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia. A comparison of three versus six courses

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

High-dose methotrexate as part of remission maintenance therapy for childhood acute lymphocytic leukemia: a Pediatric Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199607%2927%3A1%3C15%3A%3AAID-MPO4%3E3.0.CO%3B2-X

21 January 2018

Identifiers

10.1002/(SICI)1096-911X(199607)27:1<15::AID-MPO4>3.0.CO;2-X

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8614385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71041217&oldid=1744755480"